[Dysplasia and carcinoma in situ of the uterine cervix. Outcome of several cases].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D011230:Precancerous Conditions / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009761:Nystatin; D008795:Metronidazole; D013752:Tetracycline; D012293:Rifampin
Displasia e carcinoma in situ dell collo uterino. Evoluzione di alcuni casi